1. Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children
    Marta Flisiak-Jackiewicz et al, 2018, Canadian Journal of Gastroenterology and Hepatology CrossRef
  2. Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease
    Joeri Lambrecht et al, 2021, Frontiers in Immunology CrossRef
  3. CorMatrix Wrapped Around the Adventitia of the Arteriovenous Fistula Outflow Vein Attenuates Venous Neointimal Hyperplasia
    Binxia Yang et al, 2017, Scientific Reports CrossRef
  4. Comprehensive review of Urtica dioica L. (Urticaceae) phytochemistry and anti-inflammatory properties
    Rui Parente et al, 2024, Phytochemistry Reviews CrossRef

  5. Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH


    Mona A Hegazy et al, 2020, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
  6. Experimental models of metabolic and alcoholic fatty liver disease
    Delfin Gerard Buyco et al, 2021, World Journal of Gastroenterology CrossRef
  7. Uric acid and sCD163 as biomarkers for metabolic dysfunction and MAFLD in children and adolescents with overweight and obesity
    Sofie Orry et al, 2023, Journal of Pediatric Endocrinology and Metabolism CrossRef
  8. Lung Inflammation Predictors in Combined Immune Checkpoint-Inhibitor and Radiation Therapy—Proof-of-Concept Animal Study
    Benjamin Spieler et al, 2022, Biomedicines CrossRef